InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Hubbard John W, Director. Insider active across 1 companies, notably Agile Therapeutics INC. Aggregated, 3 filings have been logged. The latest transaction was disclosed on 9 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations3 total
0670 shares0
Common Stock
SEC:0001104659-22-070178:0·
024,510 shares0
Common Stock
SEC:0001104659-21-079620:0·
024,510 shares0
Common Stock
SEC:0001104659-21-079620·
3 of 3 declarations
About Hubbard John W
John W. Hubbard is a Director at Agile Therapeutics Inc, a biopharmaceutical company. In this role, he participates in the governance of the company and the development of its strategy. Hubbard brings valuable expertise in healthcare, allowing him to play an active role in strategic decision-making. His commitment to innovation and improving healthcare is central to his mission on the board.
